EPRX
Eupraxia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.40
+12.00%Institutional positioning
13F filings over the trailing two quarters
New 22Increased 21Reduced 6Sold out 54
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BEUTEL, GOODMAN & CO LTD. | Reduced | 3,666,465 | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 1,589,005 | May 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Unchanged | 1,350,000 | May 15, 2026 |
| VIVO CAPITAL, LLC | Unchanged | 1,350,000 | May 20, 2026 |
| SCOTIA CAPITAL INC. | Increased | 1,342,178 | May 13, 2026 |
| IKARIAN CAPITAL, LLC | Increased | 1,214,741 | May 15, 2026 |
| GREAT POINT PARTNERS LLC | Unchanged | 1,200,000 | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 967,575 | May 15, 2026 |
| UBS GROUP AG | Increased | 762,635 | May 5, 2026 |
| REDMILE GROUP, LLC | New Position | 700,000 | May 15, 2026 |
| RUBRIC CAPITAL MANAGEMENT LP | New Position | 691,170 | May 15, 2026 |
| Squadron Capital Management LLC | Increased | 680,000 | May 15, 2026 |
| ALLY BRIDGE GROUP (NY) LLC | Increased | 660,375 | May 18, 2026 |
| AMERIPRISE FINANCIAL INC | New Position | 649,074 | Jul 17, 2026 |
| PFM HEALTH SCIENCES, LP | New Position | 540,871 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings